vTv Therapeutics Inc. (VTVT) › Shareholders' EquityvTv Therapeutics Inc. (VTVT) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2012: -$180.17M2013: -$303.73M2014: -$498.81M2015: -$77.97M2016: -$90.94M2017: -$151.05M2018: -$82.85M2019: -$49.02M2020: -$80.10M2021: -$9.74M2022: -$10.74M2023: -$24.68M2024: $12.20M2025: $64.44M$64.44M2012Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$64.44M+428.2%2024$12.20M+149.4%2023-$24.68M-129.8%2022-$10.74M-10.3%2021-$9.74M+87.8%2020-$80.10M-63.4%2019-$49.02M+40.8%2018-$82.85M+45.1%2017-$151.05M-66.1%2016-$90.94M-16.6%2015-$77.97M+84.4%2014-$498.81M-64.2%2013-$303.73M-68.6%2012-$180.17M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share